• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21797 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     NIHR Health Technology Assessment programme Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma
2006     National Institute for Health and Care Excellence (NICE) Rituximab for the treatment of follicular lymphoma
2006     Quality Improvement Scotland (NHS QIS ) Rituximab for the treatment of follicular lymphoma
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for the treatment of primary membranous nephropathy
2010     National Institute for Health and Care Excellence (NICE) Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia
2009     NIHR Health Technology Assessment programme Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
2008     Quality Improvement Scotland (NHS QIS ) Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
2008     National Institute for Health and Care Excellence (NICE) Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma (review of technology appraisal guidance 37)
2010     NIHR Health Technology Assessment programme Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia
2009     NIHR Health Technology Assessment programme Rituximab for the treatment of rheumatoid arthritis
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Rituximab for the treatment of rheumatoid arthritis
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Rituximab for the treatment of rheumatoid arthritis
2007     Quality Improvement Scotland (NHS QIS ) Rituximab for the treatment of rheumatoid arthritis
2007     National Institute for Health and Care Excellence (NICE) Rituximab for the treatment of rheumatoid arthritis (replaced by TA195)
2021     Agency for Care Effectiveness (ACE) Rituximab for treating non-Hodgkin's lymphoma and chronic lymphocytic leukaemia
2002     Blue Cross Blue Shield Association (BCBS) Rituximab for treatment of intermediate and aggressive B-cell non-Hodgkin's lymphomas
2013     NIHR Health Technology Assessment programme Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
2007     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Bay 59-7939) for the prevention of venous thromboembolism (VTE) after major orthopaedic surgery: horizon scanning technology briefing
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rivaroxaban (Xarelto- Bayer Inc.) new Indication: pulmonary embolism
2011     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for acute coronary syndrome
2010     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for prevention of venous thromboembolism in medically ill patients
2009     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for stroke prevention in atrial fibrillation
2010     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for venous thromboembolism
2011     NIHR Health Technology Assessment programme Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation: a single technology appraisal
2012     National Institute for Health and Care Excellence (NICE) Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation. NICE technology appraisal guidance 256
2009     National Institute for Health and Care Excellence (NICE) Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults
2009     NIHR Health Technology Assessment programme Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
2012     National Institute for Health and Care Excellence (NICE) Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism. NICE technology appraisal guidance 261
2012     NIHR Health Technology Assessment programme Rivaroxaban for the treatment of deep vein thrombosis and secondary prevention of venous thromboembolism
1998     Wessex Institute for Health Research and Development (WIHRD) Rivastigmine (Exelon TM) in the treatment of senile dementia of the Alzheimer type (SDAT)
2018     Agency for Care Effectiveness (ACE) Rivastigmine for the treatment of dementia associated with Alzheimer's disease or Parkinson's disease
2010     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Robot-assisted endoscopic thyroidectomy
2022     Agency for Care Effectiveness (ACE) Robot-assisted endovascular intervention systems for coronary artery disease and other vascular diseases
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Robot-assisted surgery in prostate cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Robot-assisted surgery in thoracic and visceral indications
2019     European Network for Health Technology Assessment (EUnetHTA) Robot-assisted surgery in thoracic and visceral indications
2023     Austrian Institute for Health Technology Assessment (AIHTA) Robot-assisted surgery in thoracic and visceral indications – Update 2023
2007     Andalusian Health Technology Assessment Area (AETSA) Robot-assisted surgery using da Vinci robot telemanipulation in prostatectomy
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Robot-assisted surgery versus open surgery and laparoscopic surgery: clinical and cost-effectiveness analyses
2009     Belgian Health Care Knowledge Centre (KCE) Robot-assisted surgery: health technology assessment
2008     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Robot-assisted surgery: the da Vinci robot
2010     Adelaide Health Technology Assessment (AHTA) Robot-assisted therapy for long-term upper limb impairment after stroke
2023     Health Technology Wales (HTW) Robot-assisted thoracic surgery
2020     NIHR Health Technology Assessment programme Robot-assisted training compared with an enhanced upper limb therapy programme and with usual care for upper limb functional limitation after stroke: the RATULS three-group RCT
2024     Penn Medicine Center for Evidence-based Practice (CEP) Robot-assisted vs. laparoscopic surgery for cholecystectomy
2000     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Robotic arm for endoscopic surgery - systematic review, expert panel
2022     Malaysian Health Technology Assessment (MaHTAS) Robotic arm-assisted surgery in total hip arthroplasty, total knee arthroplasty and unicompartmental knee arthroplasty
1999     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Robotic cardiac surgery (systematic review, expert panel)
2012     Medical Services Advisory Committee (MSAC) Robotic image-guided stereotactic precise beam radiosurgery and radiotherapy for prostate and lung
2004     VA Technology Assessment Program (VATAP) Robotic surgery
2002     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Robotic surgery - systematic review, expert panel
2006     VA Technology Assessment Program (VATAP) Robotic surgery - Update 2006
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Robotic surgery versus open-chest surgery for internal mammary artery harvesting and mitral valve surgery: clinical effectiveness
2017     Health Quality Ontario (HQO) Robotic surgical system for radical prostatectomy: a health technology assessment
2017     Health Quality Ontario (HQO) Robotic surgical system for radical prostatectomy: OHTAC recommendation
2023     Ontario Health Robotic-assisted hysterectomy for endometrial cancer in people with obesity
2014     Health Quality Ontario (HQO) Robotic-assisted minimally invasive prostatectomy: OHTAC recommendation
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analaysis
2010     Medical Advisory Secretariat (MAS) Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis
2023     Ontario Health Robotic-assisted partial nephrectomy for kidney cancer
2008     HAYES, Inc. Robotic-assisted prostatectomy
2009     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Robotic-assisted surgery for urological, cardiac and gynaecological procedures
2006     HAYES, Inc. Robotically assisted adrenalectomy (da Vinci Surgical System) (Intuitive Surgical Inc.)
2007     HAYES, Inc. Robotically assisted atrial septal defect repair (da Vinci Surgical System) (Intuitive Surgical Inc.)
2010     HAYES, Inc. Robotically assisted atrial septal defect repair using the da vinci surgical system (Intuitive Surgical Inc.)
2008     HAYES, Inc. Robotically assisted cardiac valve replacement (da Vinci Surgical System) (Intuitive Surgical Inc.)
2004     HAYES, Inc. Robotically assisted coronary artery bypass surgery
2008     HAYES, Inc. Robotically assisted coronary artery bypass surgery
2014     HAYES, Inc. Robotically assisted hysterectomy
2010     HAYES, Inc. Robotically assisted hysterectomy
2008     HAYES, Inc. Robotically assisted hysterectomy (da Vinci Surgical System) (Intuitive Surgical Inc.)
2014     The Regional Health Technology Assessment Centre (HTA-centrum) Robotically assisted laparoscopic surgery for rectal cancer
2007     HAYES, Inc. Robotically assisted mitral valve repair (da Vinci Surgical System) (Intuitive Surgical Inc.)
2013     HAYES, Inc. Robotically assisted mitral valve repair using the da Vinci surgical system (Intuitive Surgical Inc.)
2010     HAYES, Inc. Robotically assisted mitral valve repair using the Da Vinci surgical system (Intuitive Surgical Inc.)
2011     HAYES, Inc. Robotically assisted mitral valve repair using the da Vinci surgical system (Intuitive Surgical Inc.)
2009     HAYES, Inc. Robotically assisted nephrectomy for renal malignancy using the da Vinci surgical system (Intuitive Surgical Inc.) for adult patients
2004     HAYES, Inc. Robotically assisted prostatectomy
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery (SRS) for spinal and extracranial head and neck indications
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery for intracranial indications
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery for thoracic and abdominal indications
2004     HAYES, Inc. Robotically assisted stereotactic surgery
2021     Austrian Institute for Health Technology Assessment (AIHTA) Robotics and functional electrical stimulation for stroke rehabilitation: systematic review
2015     NIHR Horizon Scanning Centre (NIHR HSC) ROCA® for the diagnosis of ovarian cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rociletinib for advanced or recurrent non-small cell lung cancer with the EGFR T790M mutation
2021     NIHR Health Technology Assessment programme ROCkeTS - Refining Ovarian Cancer Test Accuracy Scores
2009     NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast (Daxas) for chronic obstructive pulmonary disease
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Roflumilast for asthma and chronic obstructive pulmonary disease
2004     NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast for asthma and chronic obstructive pulmonary disease - horizon scanning review
2011     NIHR Health Technology Assessment programme Roflumilast for the management of severe chronic obstructive pulmonary disease
2015     HAYES, Inc. Rolapitant (Varubi) in combination with other antiemetic drugs to prevent delayed nausea and vomiting from cancer chemotherapy
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Role and positioning of university outpatient departments
2011     Agency for Healthcare Research and Quality (AHRQ) Role of active surveillance in the management of men with localized prostate cancer
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Role of anti cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Role of anti cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Role of combination inhaled corticosteroids and long acting beta agonists in the treatment of adult asthma
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Role of CT scan and magnetic resonance imaging in pancreatic cyst diagnosis
2018     Agency for Healthcare Research and Quality (AHRQ) Role of immunotherapy in the treatment of asthma
2006     The Swedish Council on Health Technology Assessment (SBU) Role of natriuretic peptides in diagnosing heart failure - early assessment briefs (Alert)
2024     Austrian Institute for Health Technology Assessment (AIHTA) Role of public contributions to the development of health innovations and its integration in value assessment and pricing/reimbursement decisions